Dougy speak:
Discussions are ongoing with Roche's global pharmaceutical team, based in Switzerland, about how these findings can be more widely applied.
.....................
I'd say, a set time period for a response is probably out the window. Neither side would be interested in scrapping negotiations if a due date is breached.
If and when PYC/Roche move to next stage, PYCs work will have been fully validated by Roche.
This little fish is swimming in the deep blue sea with lots of predators about.
Cheers ST
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |